SCHEMBL684016

SCHEMBL684016

CC(C)(C)Nc1cccc(N=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ NOS1 P29475 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ SIGMAR1 Q99720 3/20 0.31
▸ GRIN2D O15399 2/20 0.31
▸ GRIN3B O60391 2/20 0.31
▸ GRIN1 Q05586 2/20 0.31
▸ GRIN2A Q12879 2/20 0.31
▸ GRIN2B Q13224 2/20 0.31
▸ GRIN2C Q14957 2/20 0.31
▸ GRIN3A Q8TCU5 2/20 0.31
▸ PRSS1 P07477 1/20 0.31
▸ PRSS2 P07478 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13884318 0.79 ALDH1A1 (0.42) ALDH1A1CYP3A4HTTNPSR1LMNA
SCHEMBL20388038 0.75 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL28198962 0.74 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL12335260 0.74 ALDH1A1 (0.56) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL18893124 0.73 TDP1 (0.48) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL28194088 0.73 ALDH1A1 (0.35) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL2889237 0.72 ALDH1A1 (0.41) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL2889240 0.72 ALDH1A1 (0.54) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL8966246 0.72 ALDH1A1 (0.67) ALDH1A1HSD17B10CYP3A4TSHRHTT
SCHEMBL12130854 0.72 ALDH1A1 (0.59) ALDH1A1HSD17B10MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) 2011-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL ALK, BCR, NPM1 ALDH1A1 749/4885HSD17B10 2928/4885CYP3A4 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback